Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Australian manufacturers of therapeutic goods (medicines, active pharmaceutical ingredients (APIs) and biologicals, human blood and blood components and haematopoietic progenitor cells) must apply for a manufacturing licence for an Australian manufacturing site.
For details go to Australian manufacturing licences and overseas GMP certification.